Key facts
- It has raised $15.0M.
- Notable investors include Endless Frontier Labs, 3one4 Capital, Alphatron Capital, Speciale Invest.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Fermbox
- ·The full record, as it builds
Funding rounds
No funding rounds for Fermbox are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fermbox
Developer of a synthetic biology platform designed to create and scale sustainable bio-based products. The company offers a streamlined lab-to-launch operating system that leverages precision fermentation and synthetic biology, enabling businesses to reduce dependence on petrochemical, animal-based, and environmentally harmful supply chains while ensuring regulatory compliance and sustainability.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2022
- Employees
- 23
- Website
- fermbox.bio/
- Ownership
- Privately Held (backing)
Fermbox doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fermbox shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fermbox in its N-PORT filings yet. We sweep new filings monthly.